Abstract
Background and Objective Vascular Erectile dysfunction (ED) is considered a sentinel marker for underlying cardiovascular and metabolic disorders. This systematic review and meta-analysis aim to quantify the predictive value of ED for cardiometabolic vascular diseases (CVD) in young adults as well as aging males and to explore the temporal relationship between ED onset and the development of these diseases.
Methods A comprehensive search of databases including PubMed, EMBASE, and Cochrane Library was conducted to identify relevant studies. Inclusion criteria were studies assessing the association between ED and CVD, with effect sizes reported as odds ratios (ORs) or hazard ratios (HRs). Data were extracted and pooled using random-effects meta-analysis. Sensitivity analyses, including leave-one-out analysis, and Egger’s test for publication bias, were performed.
Key Findings and Limitations
The pooled analysis of 39 studies revealed a significant association between ED and CVD with an OR of 1.42 (95% CI: 1.28-1.57).
The temporal relationship indicates that ED precedes the onset of CVD by approximately 2 to 5 years.
Endothelial dysfunction, a common pathway in ED and CVD, was highlighted through biomarkers such as flow-mediated dilation (FMD), nitric oxide (NO) levels, and C-reactive protein (CRP).
Limitations include heterogeneity among study designs and the potential for residual confounding.
Conclusions and Clinical Implications ED is a robust predictive biomarker for CVD in aging males, with significant implications for early detection and preventive strategies. Clinicians should consider cardiovascular risk assessment in patients presenting with ED to facilitate timely intervention and improve long-term outcomes.
Introduction
Erectile dysfunction (ED) is a common condition in aging males, with prevalence increasing from 40% at age 40 to about 70% by age 70 [16]. Beyond its impact on quality of life, ED is increasingly recognized as a harbinger of cardiometabolic vascular diseases (CVD), such as coronary artery disease (CAD), hypertension, and diabetes [13], [14], [18]. This systematic review and meta-analysis aims to synthesize the evidence on ED as a predictive biomarker for CVD, examining the underlying pathophysiological mechanisms and the temporal relationship between the onset of ED and the development of cardiometabolic conditions.
Methods
Literature Search and Selection
A systematic search was conducted in PubMed, EMBASE, and the Cochrane Library databases for studies published up to July 2023. Search terms included “erectile dysfunction,” “cardiovascular disease,” “coronary artery disease,” “hypertension,” “diabetes,” and “biomarker.” Inclusion criteria were observational studies and meta-analyses reporting the association between ED and CVD, with effect sizes as ORs or HRs.
Data Extraction and Quality Assessment
Data were extracted on study design, sample size, effect sizes, confidence intervals, and follow-up duration. Quality assessment was performed using standardized criteria, focusing on the reliability and validity of reported outcomes.
Statistical Analysis
Pooled ORs and 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was assessed using the I2 statistic. Sensitivity analyses, including leave-one-out analysis, were conducted to evaluate the robustness of the findings. Egger’s regression test was used to assess publication bias.
Results
Study Characteristics
Thirty-nine studies met the inclusion criteria, encompassing a total of over 450,000 participants. The studies varied in design, including cohort studies, meta-analyses, and systematic reviews.
Association Between ED and CVD
The meta-analysis demonstrated a pooled OR of 1.42 (95% CI: 1.28-1.57), indicating a significant association between ED and increased risk of CVD. Sensitivity analyses confirmed the stability of the results, with no single study disproportionately influencing the pooled effect size.
Temporal Relationship
Longitudinal studies indicated that ED often precedes the diagnosis of CVD by 2 to 5 years, emphasizing its potential role as an early marker for cardiovascular risk [17], [18], [31].
Pathophysiological Mechanisms
Endothelial dysfunction emerged as a central mechanism linking ED with CVD. Key biomarkers such as FMD, NO levels, and CRP were consistently associated with both conditions [7], [10], [28]. The shared pathophysiological pathways underscore the relevance of ED in predicting cardiometabolic diseases.
Discussion
Implications for Clinical Practice
The findings underscore the importance of considering ED not merely as a quality-of-life issue but as a significant indicator of underlying endothelial dysfunction and cardiovascular risk. Routine cardiovascular screening in patients presenting with ED could facilitate early detection and intervention, potentially mitigating the progression of CVD and other disease related to vascular health.
Strengths and Limitations
The strengths of this systematic review and meta-analysis include a comprehensive search strategy, rigorous inclusion criteria, and robust statistical analysis methods, which collectively enhance the validity and reliability of the findings. Additionally, the large sample size and diversity of included studies strengthen the generalizability of the results.
Heterogeneity: The included studies vary in design, population characteristics, and diagnostic criteria for both ED and CVD, which introduces heterogeneity into the analysis.
Residual Confounding: While many studies adjusted for confounders, the potential for residual confounding cannot be entirely ruled out. Factors such as lifestyle, comorbid conditions, and medication use may influence the observed associations.
Publication Bias: Although Egger’s test and funnel plot analyses did not reveal significant publication bias, the possibility of unpublished studies with null results remains.
Temporal Relationship: The exact temporal relationship between ED onset and CVD development is challenging to establish definitively due to the varying follow-up durations and retrospective nature of some studies.
Future Directions
Further research should focus on:
Prospective Cohort Studies: Long-term, large-scale prospective cohort studies are needed to confirm the temporal relationship and causality between ED and CVD.
Mechanistic Studies: Investigating the underlying biological mechanisms through which ED contributes to the development of CVD will provide deeper insights and potential therapeutic targets.
Integrated Care Models: Developing and evaluating integrated care models that include routine cardiovascular risk assessment and management in men with ED could improve outcomes.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Footnotes
minor corrections to study text grammar and structure
References
